Research at Taizhou Enze Medical Center in China focused on the risk priority of adverse events during all phases of emergency laboratory analysis, and it implemented continuous systematic ...

Poor communication contributed to 24% of safety incidents in 42 studies that examined its contribution along with other causes.

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Fractyl Health (GUTS) announced positive early data from the open-label REVEAL-1 cohort of its ongoing REMAIN-1 pivotal study. The results ...

Devices Inc. , a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary unaudited financial ...

Positioning of Diamyd® Positioning of Diamyd ® Diamyd® is a precision immunotherapy targeting individuals with a specific HLA genotype associated with Type 1 Diabetes. Over 1,000 patients have been ...

Below is a concise month-by-month overview of expected results from daily use of one Prime Biome gummy, based on its claims, ...

A coroner has voiced concerns over an internal hospital investigation into the death of an elderly woman who died after being pushed over by another patient ... of the root cause analysis report ...

This action was taken after the company received reports of complications, the cause of which could not immediately be explained. “As much as we believe in the enVista platform, patient safety ...

Users say they feel relief from burning feet, numb fingers, nerve zaps, and leg cramps within weeks. More impressively, many report lasting improvements in mobility, energy, and sleep -especially when ...

You’re a patient in a hospital, it’s late at night, and you really have to use the bathroom. There are no nurses or other medical staff in sight, so you ease yourself out of the bed and make your way ...

ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, today ...